To further substantiate the clinical value of circulating markers of T-cell chemotaxis, we also tested whether the plasma levels of 16 putative ligands for CCR1, 4 and/or 5 were different as a function of NPC recurrence in Cohort 2. Here, CCR1 is linked to nasopharyngeal carcinoma.